Similac "1st Choice Of Doctors" Claim Injunction Reversed
This article was originally published in The Tan Sheet
Executive Summary
Abbott Labs plans to resume use of the "1st Choice of Doctors" claim in labeling and advertising for Similac infant formula following a Jan. 5 federal appellate ruling overturning a preliminary injunction restricting use of the statement.